BioMed Research International
Volume 2019 (2019), Article ID 6870815, 1 page
https://doi.org/10.1155/2019/6870815

Corrigendum

Corrigendum to “Herpesvirus BACs: Past, Present, and Future”

Charles Warden,¹ Qiyi Tang,² and Hua Zhu³

¹Department of Molecular Medicine, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA 91010, USA
²Department of Microbiology/AIDS Research Program, Ponce School of Medicine, 395 Zona Industrial, Reparada 2, Ponce, PR 00716-2348, USA
³Department of Microbiology and Molecular Genetics, UMDNJ-New Jersey Medical School, 225 Warren Street, Newark, NJ 07101-1709, USA

Correspondence should be addressed to Hua Zhu; zhuhu@njms.rutgers.edu

Received 17 December 2018; Accepted 20 December 2018; Published 8 July 2019

Copyright © 2019 Charles Warden et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “Herpesvirus BACs: Past, Present, and Future” [1], there was an error in the second paragraph in the “Studies of Specific Herpesvirus BACs” section, where the text reading “For example, AD169, Towne, and TB40 are considered the “clinical” BAC strains whereas Toledo, FIX, PH, and TR are considered to be the “laboratory” BAC strains ” should be corrected to “For example, AD169, Towne, and TB40 are considered the “laboratory” BAC strains whereas Toledo, FIX, PH, and TR are considered to be the “clinical” BAC strains .”

References

C. Warden, Q. Tang, and H. Zhu, “Herpesvirus BACs: past, present, and future,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 124595, 16 pages, 2011.